ZEMBRACE SYMTOUCH

Peak

sumatriptan succinate

NDASUBCUTANEOUSSOLUTION

Approved

Jan 2016

Lifecycle

Peak

Competitive Pressure

0/100

Clinical Trials

Clinical Trials (5)

NCT00875784Phase 1Completed

An Open-label, Randomized, 3-period Crossover Study to Evaluate Sumatriptan Pharmacokinetics for a TREXIMA™ (Sumatriptan Succinate / Naproxen Sodium) Tablet Followed by IMITREX® (Sumatriptan Succinate)

Started May 2008

30 enrolled

Migraine Disorders

NCT00382993Phase 3Completed

A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)

Started Dec 2006

169 enrolled

Migraine Disorders

NCT00383162Phase 3Completed

A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)

Started Nov 2006

173 enrolled

Migraine Disorders

NCT00356603Phase 3Completed

Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan

Started Jun 2006

75 enrolled

Migraine Disorders

NCT00846885Phase 1Completed

Sumatriptan Succinate 100 mg Tablets Under Non-Fasting Conditions

Started Aug 2004

28 enrolled